Reduction of thyroid hormone may participate in the modulation of cytochromes P450 2C11 and 3A2 by retinol

Life Sciences

Volumn 63, Issue 25, 1998, Pages

  Badger, Drew ^a   Kraner, James ^b   Fraser, David ^a   Hoglen, Niel ^a   Halpert, James ^a   Sipes, I Glenn ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b AIT Laboratories   (United States)

Author keywords

Cytochrome P450; Retinol; Thyroid hormone

Indexed keywords

CYTOCHROME P450 ISOENZYME; PROGESTERONE; RETINOL; TESTOSTERONE; THYROID HORMONE; THYROXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; HYPOTHYROIDISM; LIVER MICROSOME; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT;

ANIMALIA;

EID: 0032514956     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00516-5     Document Type: Article

References (20)

1. 1. D.A. BADGER, J-M. SAUER, N.C. HOGLEN, C.S. JOLLEY, and I.G. SIPES, Toxicol. Appl. Pharmacol. 141 507-519 (1996).
2. 2. S. BANDIERA, and C. DWORSCHAK, Arch. Biochem. Biophys. 296 286-295 (1992).
3. 3. G. BEDO, P. SANTISTEBAN, and A. ARANDA, Nature 339 231-234 (1989).
4. 4. J.J. BREEN, T. MATSUURA, A.C. ROSS, and J.A. GURR, Endocrinol. 136 543-549 (1995).
5. 5. A.E. ELSISI, D.L. EARNEST, AND I.G. SIPES, Toxicol. Appl. Pharmacol., 119 295-301 (1993c).
6. 6. L.J. GUDAS, M.B. SPORN, and A.B. ROBERTS, The Retinoids; Biology, Chemistry, and Medicine, M.B. Sporn, A.B. Roberts, and D.S. Goodman (eds.), 443-520 Raven Press Ltd., New York (1994).
7. 7. F.P. GUENGERICH, Principles and Methods of Toxicology, A.W. Hayes, (Ed.), 777-814, Raven Press, Ltd., New York (1989).
8. 8. J-A. GUSTAFSSON, A. MODE, G. NORSTEDT, P. SKETT, Annu. Rev. Physiol 45 51-60 (1983).
9. 9. A.C. GUYTON, Textbook of Medical Physiology (M.J. Wonsiewicz ed.), 831-841, Saunders Company, Pennsylvania (1991)
10. 10. P.S. GUZELIAN, D. LI, E.G. SCHUETZ, P. THOMAS, W. LEVIN, A. MODE, and J.A. GUSTAFSSON, Proc. Natl. Acad. Sci. USA 85 9783-9787 (1988).
11. 11. J-O. JANSSON, S. EDEN, O. ISAKSSON, Endocrinol. Rev. 6 128-150 (1985).
12. 12. J.C. KRANER, E.T. MORGAN, AND J.R. HALPERT, J. Pharmacol. Exp. Ther., 270 1367-1372 (1994).
13. 13. J.C. KRANER, E.T. MORGAN, T.S. POET, S.L. BORN, V.L. BURNETT, and J.R. HALPERT, J. Pharmacol. Exp. Ther. 276 258-264 (1996).
14. 14. R. MARTINI, A.M. BUTLER, X. JIANG, and M. MURRAY, J. Pharmacol. Exp. Ther. 273 427-434 (1995).
15. 15. E.T. MORGAN, C. MACGEOCH, and J-A. GUSTAFSSON, J. Biol. Chem. 260 11895-11898 (1985).
16. 16. M. MURRAY, E. CANTRILL, R. MARTINI, and G.C. FARRELL, Arch. Biochem. Biophys. 286 618-624 (1991).
17. 17. P. RAM, and D.J. WAXMAN, J. Pharmacol. Exp. Ther. 270(3) 1367-1372 (1991).
18. 18. P. SKETT, Prog. Drug Metab. 10 85-139 (1987).
19. 19. D.J. WAXMAN, J. Steroid Biochem. Mol. Biol. 43 1055-1072 (1992).
20. 20. D.J. WAXMAN, P.A. RAM, G. NOTANI, G.A. LEBLANC, J.A. ALBERTA, J.J. MORRISSEY, and S.S. SUNDSETH, Mol. Endocrinol. 4(3) 447-454 (1990).